Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)

• Company Description    agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. Number of Employees: 856

• Price / Volume Information    Yesterday's Closing Price: $86.39 Daily Weekly Monthly 20 Day Moving Average: 605,390 shares Shares Outstanding: 16.68 (millions) Market Capitalization: $1,441.33 (millions) Beta: 2.29 52 Week High: $90.48 52 Week Low: $7.48 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 228.23% 212.20% 12 Week 481.16% 437.26% Year To Date 401.76% 330.23%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 440 Polaris Parkway Suite 550 - Westerville,OH 43082 USA ph: 562-256-3800 fax: - investors@agilonhealth.com http://agilonhealth.com

• General Corporate Information    Officers Ronald A. Williams - Chairman Ravi Sachdev - Vice Chairman Jeffrey Schwaneke - Chief Financial Officer Timothy Gertsch - Chief Accounting Officer Sharad Mansukani - Director Peer Information Agilon Health, Inc. (CHCR) Agilon Health, Inc. (ESRX) Agilon Health, Inc. (MYDP) Agilon Health, Inc. (COR) Agilon Health, Inc. (GBCS) Agilon Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00857U206 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/03/26 Share - Related Items Shares Outstanding: 16.68 Most Recent Split Date: 3.00 (0.04:1) Beta: 2.29 Market Capitalization: $1,441.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.27 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.75 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 53.28% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.94 Price/Cash Flow: - Price / Sales: 0.25 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 115.65% Sales Growth vs. Year Ago Period: -7.33% vs. Previous Quarter: -9.50% ROE 03/31/26 - -146.03 12/31/25 - -120.82 09/30/25 - -75.92 ROA 03/31/26 - -24.55 12/31/25 - -24.89 09/30/25 - -18.35 Current Ratio 03/31/26 - 1.04 12/31/25 - 1.02 09/30/25 - 1.08 Quick Ratio 03/31/26 - 1.04 12/31/25 - 1.02 09/30/25 - 1.08 Operating Margin 03/31/26 - -6.42 12/31/25 - -6.83 09/30/25 - -5.44 Net Margin 03/31/26 - -6.09 12/31/25 - -6.60 09/30/25 - -5.24 Pre-Tax Margin 03/31/26 - -6.40 12/31/25 - -6.81 09/30/25 - -5.46 Book Value 03/31/26 - 10.88 12/31/25 - 7.64 09/30/25 - 18.46 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.08 12/31/25 - 0.12 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 7.77 12/31/25 - 11.05 09/30/25 - 0.00

Powered by Zacks Investment Research ©